Ohnuma K - Search Results

1

A novel role for CD26/dipeptidyl peptidase IV as a therapeutic target.

Ohnuma K, Hatano R, Komiya E, Otsuka H, Itoh T, Iwao N, Kaneko Y, Yamada T, Dang NH, Morimoto C. Ohnuma K, et al. Front Biosci (Landmark Ed). 2018 Jun 1;23(9):1754-1779. doi: 10.2741/4671. Front Biosci (Landmark Ed). 2018. PMID: 29772527 Free article. Review.

2

In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299.

Ho L, Aytac U, Stephens LC, Ohnuma K, Mills GB, McKee KS, Neumann C, LaPushin R, Cabanillas F, Abbruzzese JL, Morimoto C, Dang NH. Ho L, et al. Among authors: ohnuma k. Clin Cancer Res. 2001 Jul;7(7):2031-40. Clin Cancer Res. 2001. PMID: 11448921

3

Expression of CD26 and its associated dipeptidyl peptidase IV enzyme activity enhances sensitivity to doxorubicin-induced cell cycle arrest at the G(2)/M checkpoint.

Aytac U, Claret FX, Ho L, Sato K, Ohnuma K, Mills GB, Cabanillas F, Morimoto C, Dang NH. Aytac U, et al. Among authors: ohnuma k. Cancer Res. 2001 Oct 1;61(19):7204-10. Cancer Res. 2001. PMID: 11585756

4

CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO.

Ishii T, Ohnuma K, Murakami A, Takasawa N, Kobayashi S, Dang NH, Schlossman SF, Morimoto C. Ishii T, et al. Among authors: ohnuma k. Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12138-43. doi: 10.1073/pnas.211439098. Epub 2001 Oct 2. Proc Natl Acad Sci U S A. 2001. PMID: 11593028 Free PMC article.

5

Soluble CD26/dipeptidyl peptidase IV induces T cell proliferation through CD86 up-regulation on APCs.

Ohnuma K, Munakata Y, Ishii T, Iwata S, Kobayashi S, Hosono O, Kawasaki H, Dang NH, Morimoto C. Ohnuma K, et al. J Immunol. 2001 Dec 15;167(12):6745-55. doi: 10.4049/jimmunol.167.12.6745. J Immunol. 2001. PMID: 11739489

6

Soluble CD26/dipeptidyl peptidase IV enhances transendothelial migration via its interaction with mannose 6-phosphate/insulin-like growth factor II receptor.

Ikushima H, Munakata Y, Iwata S, Ohnuma K, Kobayashi S, Dang NH, Morimoto C. Ikushima H, et al. Among authors: ohnuma k. Cell Immunol. 2002 Jan;215(1):106-10. doi: 10.1016/s0008-8749(02)00010-2. Cell Immunol. 2002. PMID: 12142042

7

G1/S cell cycle arrest provoked in human T cells by antibody to CD26.

Ohnuma K, Ishii T, Iwata S, Hosono O, Kawasaki H, Uchiyama M, Tanaka H, Yamochi T, Dang NH, Morimoto C. Ohnuma K, et al. Immunology. 2002 Nov;107(3):325-33. doi: 10.1046/j.1365-2567.2002.01510.x. Immunology. 2002. PMID: 12423308 Free PMC article.

8

Effect of CD26/dipeptidyl peptidase IV on Jurkat sensitivity to G2/M arrest induced by topoisomerase II inhibitors.

Aytac U, Sato K, Yamochi T, Yamochi T, Ohnuma K, Mills GB, Morimoto C, Dang NH. Aytac U, et al. Among authors: ohnuma k. Br J Cancer. 2003 Feb 10;88(3):455-62. doi: 10.1038/sj.bjc.6600791. Br J Cancer. 2003. PMID: 12569391 Free PMC article.

9

SS-A/Ro52, an autoantigen involved in CD28-mediated IL-2 production.

Ishii T, Ohnuma K, Murakami A, Takasawa N, Yamochi T, Iwata S, Uchiyama M, Dang NH, Tanaka H, Morimoto C. Ishii T, et al. Among authors: ohnuma k. J Immunol. 2003 Apr 1;170(7):3653-61. doi: 10.4049/jimmunol.170.7.3653. J Immunol. 2003. PMID: 12646630

10

CD26/dipeptidyl peptidase IV enhances expression of topoisomerase II alpha and sensitivity to apoptosis induced by topoisomerase II inhibitors.

Sato K, Aytac U, Yamochi T, Yamochi T, Ohnuma K, McKee KS, Morimoto C, Dang NH. Sato K, et al. Among authors: ohnuma k. Br J Cancer. 2003 Oct 6;89(7):1366-74. doi: 10.1038/sj.bjc.6601253. Br J Cancer. 2003. PMID: 14520473 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters